Quantbot Technologies’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Quantbot Technologies’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,952	Closed	-$541K	–	2069
2023 Q1	$541K	Sell	5,952 -3,758	-39%	-$221K	0.04%	590
2022 Q4	$369K	Sell	9,710 -4,219	-30%	-$145K	0.03%	686
2022 Q3	$350K	Buy	+13,929	New	+$386K	0.03%	703
2021 Q3	–	Sell	-1,193	Closed	-$168K	–	2029
2021 Q2	$168K	Buy	1,193 +1,122	+1,580%	+$127K	0.01%	789
2021 Q1	$7K	Sell	71 -263	-79%	-$30.7K	﹤0.01%	1281
2020 Q4	$41K	Sell	334 -823	-71%	-$108K	﹤0.01%	893
2020 Q3	$112K	Buy	+1,157	New	+$145K	0.01%	702
2020 Q2	–	Sell	-135	Closed	-$19K	–	1521
2020 Q1	$19K	Buy	+135	New	+$26.1K	0.01%	602
2018 Q3	–	Sell	-3,352	Closed	-$117K	–	1627
2018 Q2	$117K	Buy	+3,352	New	+$102K	0.01%	849

Other funds holding RETA

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quantbot Technologies's RETA Position: Q2 2023 in Review

Quantbot Technologies sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q2 2023, closing a stake of 5,952 shares — an estimated $541K sold.

Quantbot Technologies first reported a position in RETA in Q2 2018 and held it in 9 quarters. The position peaked at $541K in Q1 2023. 214 funds tracked by Wall St. Rank hold RETA as of Q2 2023.

Quantbot Technologies reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Quantbot Technologies sold 5,952 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q2 2023, an estimated $541K.
Quantbot Technologies first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q2 2018 and held it in 9 quarters.
Quantbot Technologies's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $541K in Q1 2023.
214 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q2 2023.

Based on Quantbot Technologies's 13F filing for Q2 2023, filed 8 Aug 2023.